Literature DB >> 3700648

Stimulation of cholesteryl ester synthesis in mouse peritoneal macrophages by cholesterol-rich very low density lipoproteins from the Watanabe heritable hyperlipidemic rabbit, an animal model of familial hypercholesterolemia.

T Kita, M Yokode, Y Watanabe, S Narumiya, C Kawai.   

Abstract

Cholesterol-rich very low density lipoproteins (VLDL) from the homozygous Watanabe heritable hyperlipidemic (WHHL) rabbit induced marked cholesteryl ester accumulation in mouse peritoneal macrophages. This WHHL rabbit, an animal model of human familial hypercholesterolemia, has severe hypercholesterolemia, cutaneous xanthomas, and fulminant atherosclerosis due to the deficiency of the low density lipoprotein (LDL) receptor. When incubated with mouse peritoneal macrophages, the VLDL from WHHL rabbit (WHHL-VLDL) stimulated cholesteryl [14C]oleate synthesis 124-fold more than did VLDL from the normal Japanese White rabbit (control-VLDL). The enhancement in cholesteryl ester synthesis and accumulation of WHHL-VLDL was due to the presence of a high affinity binding receptor site on the macrophage cell surface that mediated the uptake and lysosomal degradation of WHHL-VLDL. Competition studies showed that the uptake and degradation of 125I-WHHL-VLDL was inhibited by unlabeled excess WHHL-VLDL and beta-migrating VLDL (beta-VLDL), but not LDL. Furthermore, the degradation of WHHL-VLDL was not blocked by either fucoidin, polyinosinic acid, or polyguanylic acid, potent inhibitors of the acetylated (acetyl)-LDL binding site, or by acetyl-LDL. These results suggest that macrophages possess a high affinity receptor that recognizes the cholesterol-rich VLDL present in the plasma of the WHHL rabbit and that the receptor which mediates ingestion of WHHL-VLDL seems to be the same as that for beta-VLDL and leads to cholesteryl ester deposition within macrophages. Thus the uptake of the cholesterol-rich VLDL from the WHHL rabbit by macrophages in vivo may play a significant role in the pathogenesis of atherosclerosis in the WHHL rabbit.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3700648      PMCID: PMC424546          DOI: 10.1172/JCI112458

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Changes in the endothelium of the aorta and the behaviour of macrophages in experimental atheroma of rabbits.

Authors:  J C POOLE; H W FLOREY
Journal:  J Pathol Bacteriol       Date:  1958-04

Review 2.  Lipoproteins and atherosclerosis. A look back and a look ahead.

Authors:  D Steinberg
Journal:  Arteriosclerosis       Date:  1983 Jul-Aug

Review 3.  Lipoprotein receptors and cholesterol homeostasis.

Authors:  R W Mahley; T L Innerarity
Journal:  Biochim Biophys Acta       Date:  1983-05-24

4.  Metabolism of cationized lipoproteins by human fibroblasts. Biochemical and morphologic correlations.

Authors:  S K Basu; R G Anderson; J L Goldstein; M S Brown
Journal:  J Cell Biol       Date:  1977-07       Impact factor: 10.539

5.  Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages.

Authors:  A M Fogelman; I Shechter; J Seager; M Hokom; J S Child; P A Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

6.  Concentration and composition of lipoproteins in blood plasma of the WHHL rabbit. An animal model of human familial hypercholesterolemia.

Authors:  R J Havel; T Kita; L Kotite; J P Kane; R L Hamilton; J L Goldstein; M S Brown
Journal:  Arteriosclerosis       Date:  1982 Nov-Dec

7.  Cholesteryl ester synthesis in macrophages: stimulation by beta-very low density lipoproteins from cholesterol-fed animals of several species.

Authors:  R W Mahley; T L Innerarity; M S Brown; Y K Ho; J L Goldstein
Journal:  J Lipid Res       Date:  1980-11       Impact factor: 5.922

8.  Cholesteryl ester accumulation in mouse peritoneal macrophages induced by beta-migrating very low density lipoproteins from patients with atypical dysbetalipoproteinemia.

Authors:  T P Bersot; T L Innerarity; R W Mahley; R J Havel
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

9.  Saturation and suppression of hepatic lipoprotein receptors: a mechanism for the hypercholesterolemia of cholesterol-fed rabbits.

Authors:  P T Kovanen; M S Brown; S K Basu; D W Bilheimer; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

10.  Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins.

Authors:  M S Brown; J L Goldstein; M Krieger; Y K Ho; R G Anderson
Journal:  J Cell Biol       Date:  1979-09       Impact factor: 10.539

View more
  5 in total

1.  High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification.

Authors:  Y Nagano; H Arai; T Kita
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

2.  Cholesteryl ester accumulation in macrophages incubated with low density lipoprotein pretreated with cigarette smoke extract.

Authors:  M Yokode; T Kita; H Arai; C Kawai; S Narumiya; M Fujiwara
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

3.  Lapaquistat acetate, a squalene synthase inhibitor, changes macrophage/lipid-rich coronary plaques of hypercholesterolaemic rabbits into fibrous lesions.

Authors:  M Shiomi; S Yamada; Y Amano; T Nishimoto; T Ito
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

4.  Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.

Authors:  T Kita; Y Nagano; M Yokode; K Ishii; N Kume; A Ooshima; H Yoshida; C Kawai
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

5.  Stimulated arachidonate metabolism during foam cell transformation of mouse peritoneal macrophages with oxidized low density lipoprotein.

Authors:  M Yokode; T Kita; Y Kikawa; T Ogorochi; S Narumiya; C Kawai
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.